UVA Health is among the first in the U.S. to offer BiTE therapy to small cell lung cancer patients in the outpatient setting.
Author: Megan Davis (Page 2)
Learn how this therapy can offer a critical second-line option for your stage 4 small cell lung cancer patients.
Targeting the transcription factors that drive certain cancers could lead to more effective, less toxic treatments.
Recent analysis from the SHINE trial has found a link between high blood sugar after thrombolysis and life-threatening brain bleeds, especially in patients with severe strokes.
Researchers believe understanding mutations in ER protein translocation and processing complexes will lead to improved treatments for patients with congenital disorders of glycosylation.
UVA Health's Pituitary Tumor Program ensures optimal patient outcomes through collaboration, cutting-edge techniques, and streamlined care pathways.
UVA Cancer Center researchers lead acute myeloid leukemia (AML) discovery that could pave the way for improved treatments and patient outcomes.
Two new brain tumor medications could make a significant difference in the way tumors are treated — and in the lives of patients.
Researchers in the Sontheimer lab study ways to slow memory loss in diseases like Alzheimer's by reducing inflammation in the brain.
Learn how her research could lead to new and better life-saving treatments for ovarian and pancreatic cancers.